Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Astellas Expands Scope of Collaboration with Cytokinetics in Skeletal Muscular Disease Field
December 25, 2014
- NDA for Selexipag Filed in US by Actelion: Nippon Shinyaku
December 25, 2014
- Fujifilm Completes Acquisition of Kalon Biotherapeutics
December 24, 2014
- AZ, Quintiles Create New Drug Development Team, Fusing Pharma’s Expertise with CRO’s Knowhow
December 24, 2014
- Ono Licenses Exclusive Worldwide Rights for BTK Inhibitor to Gilead Excluding East and South East Asia
December 22, 2014
- Chugai, Yakult File Xeloda, Elplat for Postoperative Adjuvant Chemotherapy for Gastric Cancer
December 22, 2014
- Poteligeo Now Indicated for Chemotherapy-Naïve CCR4-Positive ATL: Kyowa Kirin
December 19, 2014
- Taiho’s Abraxane Gets Nod for Unresectable Pancreatic Cancer
December 19, 2014
- Takeda Names Sanofi’s Plump as New R&D Head
December 19, 2014
- MTPC Reorganizing Its US Affiliates to Accelerate Operation Expansion
December 19, 2014
- Fujifilm Holdings Makes J-TEC Its Consolidated Subsidiary
December 19, 2014
- Daiichi Sankyo Looks to Bring Annual 8-10 Projects into Clinical Phase, Open Innovation Key to Success: R&D Execs
December 18, 2014
- CRO Intellim to Collaborate with Indian Firm for CDISC
December 18, 2014
- Novartis Confirms Additional Cases of Employee Involvement in IIT, but Denies Falsification or Manipulation of Data
December 18, 2014
- Ribomic to Extend Joint Research Term by 1 Year with Otsuka for Hematological Disorder, Fibrosis Projects
December 18, 2014
- Chugai to File for Approval of Xeloda as Gastric Cancer Adjuvant Therapy by Year-End
December 17, 2014
- Xtandi Demonstrates Clinical Benefit for Advanced Breast Cancer in PII Study: Astellas
December 17, 2014
- Battle Begins for Blopress Generics
December 16, 2014
- Eliquis the First NOAC with Safety Information Announced for Over 100,000 Patients
December 16, 2014
- Kaketsuken, Teijin Pharma Initiate Voluntary Recall of Venilon after Wool Fiber Found in Vial of Dissolved Product
December 16, 2014
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…